Werbung
Werbung

ITRM

ITRM logo

Iterum Therapeutics plc Ordinary Share

0.34
USD
Gesponsert
-0.02
-4.18%
08. Jan., 15:59 UTC -5
Geschlossen
exchange

Nach-Markt

0.35

+0.01
+3.20%

ITRM Ergebnisberichte

Positives Überraschungsverhältnis

ITRM übertreffen die 17 der letzten 29Schätzungen.

59%

Nächster Bericht

Datum des nächsten Berichts
05. Feb. 2026
Estimate for Q4 25 (Revenue/ EPS)
$3.07M
/
-$0.09
Implizierte Änderung von Q3 25 (Revenue/ EPS)
+685.92%
/
-55.00%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
--
/
-60.87%

Iterum Therapeutics plc Ordinary Share earnings per share and revenue

On 14. Nov. 2025, ITRM reported earnings of -0.20 USD per share (EPS) for Q3 25, missing the estimate of -0.11 USD, resulting in a -78.25% surprise. Revenue reached 390.00 tausend, compared to an expected --, with a 0.00% difference. The market reacted with a -16.11% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analysts forecast an EPS of -0.09 USD, with revenue projected to reach 3.07 million USD, implying an decrease of -55.00% EPS, and increase of 685.92% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Citius Pharmaceuticals Inc. Common
Report Date
26. Dez. 2025 For Q4 25
Estimate
-$0.49
Aktuell
-
Überraschung
-
FAQ
For Q3 2025, Iterum Therapeutics plc Ordinary Share reported EPS of -$0.20, missing estimates by -78.25%, and revenue of $390.00K, 0% as expectations.
The stock price moved down -16.11%, changed from $0.56 before the earnings release to $0.47 the day after.
The next earning report is scheduled for 05. Feb. 2026.
Based on 4 analysts, Iterum Therapeutics plc Ordinary Share is expected to report EPS of -$0.09 and revenue of $3.07M for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung